Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design

1988 ◽

pp. 267-275

Author(s):

F. Andrew Dorr ◽

Michael A. Friedman

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Trial Design ◽

Clinical Trial Design

Download Full-text

Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.414 ◽

2020 ◽

Vol 108 (3) ◽

pp. e854

Author(s):

V. Muralidhar ◽

M. Alshalalfa ◽

D.E. Spratt ◽

S. Liu ◽

R.J. Karnes ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

High Risk ◽

Trial Design ◽

Clinical Trial Design ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Clinical Genomic

Download Full-text

Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design

Nature Clinical Practice Urology ◽

10.1038/ncpuro0809 ◽

2007 ◽

Vol 4 (7) ◽

pp. 362-363

Author(s):

Andrew J Stephenson

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

At Risk ◽

Trial Design ◽

Clinical Trial Design ◽

Specific Mortality ◽

Patients At Risk ◽

Cancer Specific Mortality

Download Full-text

Dietary trial in prostate cancer: Early experience and implications for clinical trial design

Urology ◽

10.1016/s0090-4295(00)00974-2 ◽

2001 ◽

Vol 57 (4) ◽

pp. 200-201 ◽

Cited By ~ 38

Author(s):

Dean M Ornish ◽

Keith L Lee ◽

William R Fair ◽

Elaine B Pettengill ◽

Peter R Carroll

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Trial Design ◽

Clinical Trial Design ◽

Early Experience

Download Full-text

Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design

Frontiers in Oncology ◽

10.3389/fonc.2016.00167 ◽

2016 ◽

Vol 6 ◽

Cited By ~ 9

Author(s):

Ima Paydar ◽

Robyn A. Cyr ◽

Thomas M. Yung ◽

Siyuan Lei ◽

Brian Timothy Collins ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Radiation Therapy ◽

Trial Design ◽

Stereotactic Body Radiation Therapy ◽

Clinical Trial Design ◽

Stereotactic Body Radiation

Download Full-text

Prevalence of homologous recombination deficiency (HRD) mutations in localized prostate cancer according to Gleason grade: Implications for neoadjuvant clinical trial design.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5062 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5062-5062

Author(s):

Catherine Handy ◽

Alexander S Baras ◽

Tamara L. Lotan ◽

Emmanuel S. Antonarakis

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Homologous Recombination ◽

Trial Design ◽

Clinical Trial Design ◽

Localized Prostate Cancer ◽

Gleason Grade ◽

Homologous Recombination Deficiency

Download Full-text

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Frontiers in Oncology ◽

10.3389/fonc.2015.00077 ◽

2015 ◽

Vol 5 ◽

Cited By ~ 8

Author(s):

Jennifer Ai-Lian Woo ◽

Leonard N. Chen ◽

Hongkun Wang ◽

Robyn A. Cyr ◽

Onita Bhattasali ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Radiation Therapy ◽

Trial Design ◽

Stereotactic Body Radiation Therapy ◽

Clinical Trial Design ◽

Patient Reported Outcome ◽

Stereotactic Body Radiation ◽

Patient Reported

Download Full-text

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

Expert Opinion on Biological Therapy ◽

10.1517/14712590903321421 ◽

2009 ◽

Vol 10 (1) ◽

pp. 19-28 ◽

Cited By ~ 22

Author(s):

Ravi A Madan ◽

Mahsa Mohebtash ◽

Jeffrey Schlom ◽

James L Gulley

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Trial Design ◽

Clinical Trial Design ◽

Castration Resistant Prostate Cancer ◽

Therapeutic Vaccines ◽

Castration Resistant

Download Full-text

Stereotactic Body Radiation Therapy for Prostate Cancer: What Is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.05.2065 ◽

2014 ◽

Vol 90 (1) ◽

pp. S705

Author(s):

J.A. Woo ◽

L.N. Chen ◽

H. Wang ◽

J.S. Kim ◽

T.M. Yung ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Radiation Therapy ◽

Trial Design ◽

Stereotactic Body Radiation Therapy ◽

Clinical Trial Design ◽

Patient Reported Outcome ◽

Stereotactic Body Radiation ◽

Patient Reported

Download Full-text

Overall survival (OS) analysis of a phase II study using a pox viral-based vaccine, PSA-TRICOM, in the treatment of metastatic, castrate-resistant prostate cancer (mCRPC): Implications for clinical trial design

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.3005 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 3005-3005 ◽

Cited By ~ 4

Author(s):

R. A. Madan ◽

J. L. Gulley ◽

W. L. Dahut ◽

K. Y. Tsang ◽

S. M. Steinberg ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Overall Survival ◽

Phase Ii ◽

Trial Design ◽

Phase Ii Study ◽

Clinical Trial Design ◽

Castrate Resistant Prostate Cancer ◽

Castrate Resistant

Download Full-text

Emerging treatments in management of prostate cancer: biomarker validation and endpoints for immunotherapy clinical trial design

Clinical Trial Design for Cytotoxics in Prostate Cancer

Clinical-Genomic Sub-classification of High-Risk Prostate Cancer: Implications for Tailoring Therapy and Clinical Trial Design

Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design

Dietary trial in prostate cancer: Early experience and implications for clinical trial design

Proctitis 1 Week after Stereotactic Body Radiation Therapy for Prostate Cancer: Implications for Clinical Trial Design

Prevalence of homologous recombination deficiency (HRD) mutations in localized prostate cancer according to Gleason grade: Implications for neoadjuvant clinical trial design.

Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

Stereotactic Body Radiation Therapy for Prostate Cancer: What Is the Appropriate Patient-Reported Outcome for Clinical Trial Design?

Overall survival (OS) analysis of a phase II study using a pox viral-based vaccine, PSA-TRICOM, in the treatment of metastatic, castrate-resistant prostate cancer (mCRPC): Implications for clinical trial design

Export Citation Format